Results 201 to 210 of about 87,183 (321)

A Regional Approach to a Global Challenge: A Case Report of Caudal Anesthesia for Anoplasty in Tetralogy of Fallot With Pulmonary Atresia

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
Timeline of the patient's clinical course from birth to follow‐up: (birth, diagnosis, NICU admission, prostaglandin infusion, surgery date, post‐op NICU stay, discharge and 3 month follow‐up). ABSTRACT Patients with Tetralogy of Fallot (TOF) with pulmonary atresia present high perioperative risks during non‐cardiac surgeries, making anesthetic ...
Prince Barnawal   +4 more
wiley   +1 more source

Bilateral Vocal Cord Paralysis Following Influenza A: Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
Flexible nasal endoscopy demonstrating bilateral vocal cord paralysis (BVCP) in the paramedian position. The left image demonstrates a glottic gap between the vocal cords (white arrows) in the maximally adducted position (patient saying “eeee”). Under normal circumstances the vocal cords should be touching with no glottic gap. The right image shows his
Dan H. V. Tran   +10 more
wiley   +1 more source

Silicosis Diagnosed Using Transbronchial Lung Biopsy: The Pivotal Role of Occupational History

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Pulmonary silicosis, a preventable occupational lung disease caused by chronic inhalation of crystalline silica dust in industries like construction, mining, and stone masonry, remains underdiagnosed in TB‐endemic regions due to overlapping clinical and radiological features.
Boon Hau Ng   +6 more
wiley   +1 more source

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40‐year‐old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long‐term safety for EF.
Maryam Sahebari   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy